Accounts Receivable Analyst
McKesson Corporation | |
relocation assistance
| |
United States, Tennessee | |
Nov 21, 2026 | |
|
It's More Than a Career, It's a Mission. Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day. Our Mission People who live with cancer - those who work to prevent it, fight it, and survive it - are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world. Job Summary Our Accounts Receivable Analyst is responsible for the reconciliation of client receivables in accordance with contractual agreements. Includes review of all Clinical Trial revenues and expenses, as well as interaction with various departments in order to determine the validity of charges and payments received from sponsors. This is a remote position based in the US; relocation assistance and visa sponsorship are not available. Duties include and are not limited to:
Qualifications include:
About Sarah Cannon Research Institute Sarah Cannon Research Institute (SCRI) is one of the world's leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI's research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S. Please click here to learn more about our research offerings. Online Recruiting-related Scams McKesson has become aware of online recruiting-related scams in which individuals who are not affiliated with or authorized by McKesson are using McKesson's (or affiliated entities, like CoverMyMeds or RxCrossroads) name in fraudulent emails, job postings or social media messages. In light of these scams, please bear the following in mind: McKesson Talent Advisors will never solicit money or credit card information in connection with a McKesson job application. McKesson job postings are posted on our career site: careers.mckesson.com. AI Disclosure Candidates are not dispositioned based on AI-generated assessments or autonomous decision-making. Disposition outcomes are based on pre-defined, job-related eligibility criteria and screening requirements established by the organization. When an applicant does not meet mandatory role qualifications or fails required prescreening questions, the system applies the corresponding disposition in accordance with those human-defined criteria. We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status. | |
relocation assistance
Nov 21, 2026